Merck faces threat of Â£10bn actions
600651
Merck, the beleaguered US pharmaceuticals group, could be forced to pay out as much as $18bn (Â£9.7bn) over 10 years as a result of lawsuits linked to Vioxx, its controversial arthritis drug.
22206
Internal e-mails and other documents from Merck &amp; Co. show the company fought for years to keep safety concerns from undermining the drug&#39;s commercial prospects, the Wall Street Journal reported on Monday.
697522
If its latest drug isn't approved, the pharmaceutical could face trouble.
448031
Smokers could be forced to pay Â£10 for a permit to buy tobacco if government health advisers get their way.
200299
The recall of Vioxx--an arthritis treatment taken by millions of people--is a disaster for everyone. Of course it&#39;s bad news for Merck (nyse: MRK - news - people), the drug&#39;s maker.
575614
Merck and Schering report bad news, but how much will it affect sales?
510588
BOSTON (CBS.MW) -- Pharmaceutical behemoth Merck heads to Capitol Hill Thursday to testify at a Senate hearing on whether the government should have forced the drugmaker to withdraw its Vioxx drug from the market before late September.
177898
Merck, the maker of the arthritis drug Vioxx is facing a nationwide legal assault as lawyers representing thousands of people injured or killed by the painkiller meet next week to set the groundwork for a massive action against the drug maker.
286537
A battle between insurers and drug companies could determine how many medicines will be available to beneficiaries.
497418
Britain's medicines advisory agency is now planning to publish its latest recommendations on the cost-effectiveness of drug-coated stents late next week, in a decision that could draw fire from manufacturers.
112252
Business & money: UK drugs giant, faces a surgical strike over its dismal share price performance.
473365
Merck & Co. Inc.  shares could  rise to $70 by 2010 if the drugmaker continues to deliver on  its promise of double-digit earnings growth, Barron's said in  its October 29 edition.
102650
Drugs giant Merck & Co. which pulled its blockbuster painkiller Vioxx from shelves in September, is about to become the target of hundreds of plaintiffs' lawyers, the New York Times reported on Friday.
764344
The anti-industry crusader targets pharmaceuticals.
446961
This article was reported and written by Alex Berenson, Gardiner Harris, Barry Meier and Andrew Pollack. In May 2000, executives at Merck, the pharmaceutical giant under siege for its
541938
Merck & Co. faces a dual threat from health insurers and patients' lawyers, after a U.S. study suggested its Vioxx arthritis drug carries a greater risk than rival medicines.
71093
US drugs giant Merck is to be fined an initial $20m in after losing a case brought by a user of its Vioxx painkiller.